SEATTLE & DUNDEE, Scotland--(BUSINESS WIRE)--Rosetta Biosoftware announced today that CXR Biosciences Ltd. licensed the Rosetta Resolver® system to investigate mechanisms of drug toxicity. CXR Biosciences plans to use the statistical analysis tools in the Resolver system to generate high-quality data to support its toxicological research using transcriptional profiling.
